Menu
Back to User profile » Prof. Dr. Bogusław Machaliński
Papers published by Prof. Dr. Bogusław Machaliński:
Molecular Changes in Chronic Myeloid Leukemia During Tyrosine Kinase Inhibitors Treatment. Focus on Immunological Pathways
Janowski M, Ulańczyk Z, Łuczkowska K, Sobuś A, Rogińska D, Pius-Sadowska E, Gniot M, Kozłowski K, Lewandowski K, Helbig G, Machaliński B, Paczkowska E
OncoTargets and Therapy 2022, 15:1123-1141
Published Date: 10 October 2022
Hodgkin Lymphoma as a Secondary Neoplasm During Therapy for Chronic Myeloid Leukaemia: Case Report and Review of the Literature
Paczkowska E, Janowski M, Karpińska K, Ryłów M, Zdziarska B, Poncyljusz W, Machaliński B
OncoTargets and Therapy 2021, 14:2497-2503
Published Date: 12 April 2021
Electrostatic complex of neurotrophin 4 with dendrimer nanoparticles: controlled release of protein in vitro and in vivo
Dąbkowska M, Rogińska D, Kłos P, Sobuś A, Adamczak M, Litwińska Z, Machalińska A, Machaliński B
International Journal of Nanomedicine 2019, 14:6117-6131
Published Date: 1 August 2019
Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
Cymbaluk-Płoska A, Chudecka-Głaz A, Jagodzińska A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Menkiszak J
OncoTargets and Therapy 2018, 11:1363-1372
Published Date: 13 March 2018
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients
Cymbaluk-Ploska A, Chudecka-Głaz A, Pius-Sadowska E, Sompolska-Rzechuła A, Machaliński B, Surowiec A, Menkiszak J
OncoTargets and Therapy 2017, 10:3169-3175
Published Date: 27 June 2017
The influence of intrauterine exposure to immunosuppressive treatment on changes in the immune system in juvenile Wistar rats
Kabat-Koperska J, Kolasa-Wołosiuk A, Wojciuk B, Wojciechowska-Koszko I, Roszkowska P, Krasnodębska-Szponder B, Paczkowska E, Safranow K, Gołembiewska E, Machaliński B, Ciechanowski K
Drug Design, Development and Therapy 2016, 10:2279-2288
Published Date: 14 July 2016
Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
Chudecka-Głaz AM, Cymbaluk-Płoska AA, Menkiszak JL, Pius-Sadowska E, Machaliński BB, Sompolska-Rzechuła A, Rzepka-Górska IA
OncoTargets and Therapy 2015, 8:471-485
Published Date: 23 February 2015